Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2025-12-24 @ 9:08 PM
NCT ID:
NCT02620904
Eligibility Criteria:
Inclusion Criteria:
1. Intrauterine fetal death as confirmed by absence of cardiac motion on ultrasound by Attending physician at the time of admission to the hospital.
2. Estimated gestational age greater than 20 weeks
3. Hemodynamically stable and appropriate for induction of labor as per primary clinical health team in house
4. Women with one prior low transverse cesarean delivery
Exclusion Criteria:
1. History of 2 or more low transverse cesarean deliveries
2. Prior classical cesarean delivery
3. History of abdominal myomectomy
4. Known or suspected allergic reaction to mifepristone
5. Known or suspected adrenal gland disease
6. Known or suspected bleeding diatheses or coagulopathies
7. Known or suspected use of QTc-prolonging medication
8. Known maternal medical or physical conditions that prohibits vaginal delivery
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
16 Years
Study:
NCT02620904
Study Brief:
Protocol Section:
NCT02620904